Skip to content
← Lobby register
SL
Other

Seqvera Ltd. Oy

🇪🇺 FINLANDRegistered 22/01 staff
Disclosed budget
€10,000
Meetings 12mo
0
Policy files
0
Accredited passes
0

Recent meetings

No recorded meetings with EU commissioners.

Mission & Goals

Seqvera develops and provides solutions for improvement of safety and efficacy of medical devices (2017/745, 2017/746), advanced therapy medicinal products (2007/1394) and health technology assessment (2021/2282) complemented with R&I on elimination of animal testing (2010/63/EC). Seqvera has several patented solutions being implemented in cooperation with H2020 and Horizon Europe projects. Seqvera's goals in cooperation with EU bodies is to foster development and deployment of medical innovations in clinical and healthcare practice to resolve unmet needs, improve cost-efficiency and to provide EU resilience towards security of supply and crises readiness.

EU Legislative Interests

Pharmaceutical strategy for Europe European Health Union EU4Health 3R implementation (2010/63/EC) European Green Deal European Infrastructure for Medicines European Health Emergency Preparedness and Response Authority (HERA) Innovative Health Initiative (IHI)

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

European Orthopaedic Research Society (EORS) European Connected Health Alliance (ECHA) EU chapter of Tissue Engineering and Regenerative Medicine (TERMIS)

Organisation Members

TechNet Alliance

Additional Information

No specific EU grants have been received which are related to the activities covered by the register. H2020 and HEU grants added (they do not contribute to the activities foreseen by the register). Work also have been done on voluntary basis (not paid and not charged)

Seqvera Ltd. Oy — EU Lobby Register | GovLens